Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis

Autor: van Gerven, N., van Erpecum, K., Ouden, J den, Brouwer, J., Vrolijk, J., Gevers, T.J., Drenth, J., Guichelaar, M., Bouma, G., Schreuder, T.C.M.A., van der Wouden, E.J., Baak, L.C., Stadhouders, P., Klemt-Kropp, M., Verhagen, M., Bhalla, A., Kuijvenhoven, J., Almasio, P., Alvarez, F., Andrade, R., Arikan, C., Assis, D., Bardou-Jacquet, E., Biewenga, M., Cancado, E., Cazzagon, N., Chazouillères, O., Colloredo, G., Cuarterolo, M., Dalekos, G., Debray, D., Robles-Díaz, M., Dyson, J., Efe, C., Engel, B., Ferri, S., Fontana, R., Gatselis, N., Gerussi, A., Halilbasic, E., Halliday, N., Heneghan, M., Hirschfield, G., van Hoek, B., Hørby Jørgensen, M., Indolfini, G., Iorio, R., Invernizzi, P., Jeong, S., Jones, D., Kelly, D., Kerkar, N., Lacaille, F., Lammert, C., Leggett, B., Lenzi, M., Levy, C., Liberal, R., Lleo, A., Lohse, A., Lopez, S. Ines, de Martin, E., McLin, V., Mieli-Vergani, G., Milkiewicz, P., Mohan, N., Muratori, L., Nebbia, G., van Nieuwkerk, C., Oo, Y., Ortega, A., Páres, A., Pop, T., Pratt, D., Purnak, T., Ranucci, G., Rushbrook, S., Schramm, C., Stättermayer, A., Swain, M., Tanaka, A., Taubert, R., Terrabuio, D., Terziroli, B., Trauner, M., Valentino, P., van den Brand, F., Vergani, D., Villamil, A., Wahlin, S., Ytting, H., Zachou, K., Zeniya, M., Colapietro, Francesca, Maisonneuve, Patrick, Lytvyak, Ellina, Beuers, Ulrich, Verdonk, Robert C., van der Meer, Adriaan J., van Hoek, Bart, Kuiken, Sjoerd D., Brouwer, Johannes T., Muratori, Paolo, Aghemo, Alessio, Carella, Francesco, van den Berg, Ad P., Zachou, Kalliopi, Dalekos, George N., Di Zeo-Sánchez, Daniel E., Robles, Mercedes, Andrade, Raul J., Montano-Loza, Aldo J., van den Brand, Floris F., Slooter, Charlotte D., Macedo, Guilherme, Liberal, Rodrigo, de Boer, Ynto S., Lleo, Ana

Publikováno v: In Journal of Hepatology January 2024 80(1):53-61

Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial

Autor: Leventogiannis, K., Kyriazopoulou, E., Antonakos, N., Kotsaki, A., Tsangaris, I., Markopoulou, D., Grondman, I., Rovina, N., Theodorou, V., Antoniadou, E., Koutsodimitropoulos, I., Dalekos, G., Vlachogianni, G., Akinosoglou, K., Koulouras, V., Komnos, A., Kontopoulou, T., Prekates, A., Koutsoukou, A., Meer, J.W.M. van der, Dimopoulos, G., Kyprianou, M., Netea, M.G., Giamarellos-Bourboulis, E.J.

Publikováno v: Cell Reports Medicine, 3
Cell Reports Medicine, 3, 11

Contains fulltext : 286864.pdf (Publisher’s version ) (Open Access) The state of immune activation may guide targeted immunotherapy in sepsis. In a double-blind, double-dummy randomized clinical study, 240 patients with sepsis due to lung infection

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59310e5ff2b9ed966d0ea63b917dfe5f
http://hdl.handle.net/2066/286864

aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis

Autor: Fan, R. Papatheodoridis, G. Sun, J. Innes, H. Toyoda, H. Xie, Q. Mo, S. Sypsa, V. Guha, I.N. Kumada, T. Niu, J. Dalekos, G. Yasuda, S. Barnes, E. Lian, J. Suri, V. Idilman, R. Barclay, S.T. Dou, X. Berg, T. Hayes, P.C. Flaherty, J.F. Zhou, Y. Zhang, Z. Buti, M. Hutchinson, S.J. Guo, Y. Calleja, J.L. Lin, L. Zhao, L. Chen, Y. Janssen, H.L.A. Zhu, C. Shi, L. Tang, X. Gaggar, A. Wei, L. Jia, J. Irving, W.L. Johnson, P.J. Lampertico, P. Hou, J.

Background & Aims: Hepatocellular carcinoma (HCC) is the leading cause of death in patients with chronic hepatitis. In this international collaboration, we sought to develop a global universal HCC risk score to predict the HCC development for patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::1dd9cc345ab19187c84c4023238c4886
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3103512

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.